Show an ad over header. AMP

I am the FIRST!!!

Biden is highest-spending political candidate on TV ads

After spending an additional $45.2 million on political ads this week, former Vice President Joe Biden has become the highest-spending political candidate on TV ads ever, according to data from Advertising Analytics.

By the numbers: In total, the Biden campaign has spent $582.7 million on TV ads between 2019 and 2020, officially surpassing Michael Bloomberg's record spend of roughly $582 million. Biden's spend includes his primary and general election advertising.


The big picture: More money has been spent so far this cycle on election and policy ads than any other in American history, per Advertising Analytics.

  • Roughly $7.76 billion has been dropped on political advertising so far this cycle.
  • Overall, the election is on track to become the most expensive in history.

Be smart: For the first time ever, spending on digital political advertising has slightly surpassed cable. Still, advertising spent on broadcast television — mostly at the local level — reigns supreme.

Data: Advertising Analytics; Note: Political includes all election, political and advocacy advertising; Chart: Axios Visuals

What's next: Between now and Election Day, Biden reserved another $57.5 million in TV advertising, while the Republican National Committee and Trump campaign have reserved $19.2 million. The Trump campaign itself has reserved $15 million.

  • Future Forward PAC, which supports Democrats, has reserved $42.2 million while America First Action PAC, which backs Republicans, has reserved $20.4 million.

regular 4 post ff

infinite scroll 4 pff

NIAID: AstraZeneca "may have included outdated information" in COVID vaccine announcement

NIAID said early Tuesday it's "concerned" that AstraZeneca "may have included outdated information" from a trial of its COVID-19 vaccine that "may have provided an incomplete view of the efficacy data.

Why it matters: The National Institute of Allergy and Infectious Diseases statement comes after the company announced the vaccine it developed with the University of Oxford was found to be 79% effective at preventing symptomatic COVID-19 and 100% effective against severe disease and hospitalization in a Phase III trial.

  • The institute added it's urging AstraZeneca to work with its monitoring board "to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible."

Editor's note: This a breaking news story. Please check back for updates.

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;